Optimization of in vitro fertilization programs by replacing an ovulation trigger
- Авторлар: Martazanova B.A1, Mishieva N.G1, Levkov L.A1, Gracheva A.M1, Bogatyreva K.A1, Eapen S.M2, Lapina V.S1, Abubakirov A.N1
-
Мекемелер:
- Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- I.M. Sechenov First Moscow State Medical University
- Шығарылым: № 10 (2015)
- Беттер: 73-80
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247526
- ID: 247526
Дәйексөз келтіру
Аннотация
Толық мәтін
Авторлар туралы
B. Martazanova
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: bellamart88@mail.ru
graduate student
N. Mishieva
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: nondoc555@mail.ru
MD, Senior researcher of 1st gynecology department
L. Levkov
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: l_levkov@oparina4.ru
MD, PhD, Head of Department
A. Gracheva
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: Alusha.M.Petruk@yandex.ru
graduate student
Kh. Bogatyreva
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: Eva-90-B@yandex.ru
graduate student
S. Eapen
I.M. Sechenov First Moscow State Medical University
Email: dr.snehaeapen@gmail.com
graduate student
V. Lapina
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: vslapina89@Gmail.ru
graduate student
A. Abubakirov
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: nondoc555@yahoo.com
PhD, Head of 1st gynecology department
Әдебиет тізімі
- Корнеева И.Е., Калинина Е.А., Сароян Т.Т., Смольникова В.Ю., Серебренникова К.Г., Пырегов А.В., Сухих Г.Т. Федеральные клинические рекомендации. Диагностика и лечение синдрома гиперстимуляции яичников. М.: Российское общество акушеров-гинекологов; 2013.
- Braat D.D., Schutte J.M., Bernardus R.E., Mooij T.M., van Leeuwen F.E. Maternal death related to IVF in the Netherlands 1984-2008. Hum. Reprod. 2010; 25(7): 1782-6.
- Acevedo B., Gomez-Palomares J.L., Ricciarelli E., Hernández E.R. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Fertil. Steril. 2006; 86(6): 1682-7.
- Youssef M.A., Van der Veen F., Al-Inany H.G., Griesinger G., Mochtar M.H., Aboulfoutouh I. et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst. Rev. 2011; (1): CD008046.
- Carizza C., Abdelmassih V., Abdelmassih S., Ravizzini P., Salgueiro L., Salgueiro P.T. et al. Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study. Reprod. Biomed. Online. 2008; 17(6): 751-5.
- Delvigne A., Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum. Reprod. Update. 2002; 8(6): 559-77.
- Semba S., Moriya T., Youssef E.M., Sasano H. An autopsy case of ovarian hyperstimulation syndrome with massive pulmonary edema and pleural effusion. Pathol. Int. 2000; 50(7): 549-52.
- Delvigne A., Rozenberg S. A qualitative systematic review of coasting, a procedure to avoid ovarian hyperstimulation syndrome in IVF patients. Hum. Reprod. Update. 2002; 8(3): 291-6.
- Vlahos N.F., Gregoriou O. Prevention and management of ovarian hyperstimulation syndrome. Ann. N. Y. Acad. Sci. 2006; 1092: 247-64.
- Papanikolaou E.G., Tournaye H., Verpoest W., Camus M., Vernaeve V., Van Steirteghem A., Devroey P. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum. Reprod. 2005; 20(3): 636-41.
- Корнеева И.Е., Иванова А.В., Баркалина Н.В. Синдром гиперстимуляции яичников: профилактика, диагностика, лечение (обзор литературы). Проблемы репродукции. 2004; 10(1): 43-50.
- Itskovitz J., Boldes R., Barlev A., Erlik Y., Kahana L., Brandes J.M. The induction of LH surge and oocyte maturation by GnRH analogue (buserelin) in women undergoing ovarian stimulation for in vitro fertilisation. Gynecol. Endocrinol. 1988; 2(Suppl. 2):165.
- Fauser B.C., de Jong D., Olivennes F., Wramsby H., Tay C., Itskovitz-Eldor J., van Hooren H.G. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J. Clin. Endocrinol. Metab. 2002; 87(2): 709-15.
- Kol S. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil. Steril. 2004; 81(1): 1-5.
- Youssef M.A., Van der Veen F., Al-Inany H.G., Mochtar M.H., Griesinger G., NagiMohesen M. et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane Database Syst. Rev. 2014; (10): CD008046.
- Lee T.H., Liu C.H., Huang C.C., Wu Y.L., Shih Y.T., Ho H.N. et al. Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum. Reprod. 2008; 23(1): 160-7.
- Kwee J., Schats R., McDonnell J., Themmen A., de Jong F., Lambalk C. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve. Fertil. Steril. 2008; 90(3): 737-43.
- Gardner D.K., Schoolcraft W.B. Culture and transfer of human blastocysts. Curr. Opin. Obstet. Gynecol. 1999; 11(3): 307-11.
- Humaidan P., Bungum L., Bungum M., Yding Andersen C. Rescue of corpus luteum function with periovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod. Biomed. Online. 2006; 13(2): 173-8.
- Humaidan P., Polyzos N.P., Alsbjerg B., Erb K., Mikkelsen A.L., Elbaek H.O. et al. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients. Hum. Reprod. 2013; 28(9): 2511-21.
- Bodri D., Guillén J.J., Galindo A., Mataró D., Pujol A., Coll O. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Fertil. Steril. 2009; 91(2): 365-71.
- Shapiro B.S., Daneshmand S.T., Garner F.C., Aguirre M., Hudson C. Comparison of “triggers” using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin. Fertil. Steril. 2011; 95(8): 2715-17.
- Griffin D., Feinn R., Engmann L., Nulsen J., Budinetz T., Benadiva C. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates. Fertil. Steril. 2014; 102(2): 405-9.
- Engmann L., DiLuigi A., Schmidt D., Nulsen J., Maier D., Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment withGnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil. Steril. 2008; 89(1): 84-91.
- Seyhan A., Ata B., Polat M., Son W.Y., Yarali H., Dahan M.H. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG. Hum. Reprod. 2013; 28(9): 2522-8.
- Atkinson P., Koch J., Ledger W.L. GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome: a retrospective study of OHSS risk and pregnancy rates. Aust. N. Z. J. Obstet. Gynaecol. 2014; 54(6): 581-5.